Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human alpha Synuclein ELISA Kit (AC3161)
Cat.#: ASET-1750
Specifications
Description Human alpha Synuclein ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human alpha Synuclein concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 5.15 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 40-640 pg/mL Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1807 Human Synaptotagmin VII ELISA Kit (AC3218) Quantitative inquiry ASET-1113 Human MAdCAM1 ELISA Kit (AC2524) Quantitative inquiry ASET-1331 Rat Glutamate Receptor 1 (AMPA subtype) ELISA Kit (AC2742) Quantitative inquiry ASET-1292 Human Glucose 6 Phosphate Isomerase ELISA Kit (AC2703) Quantitative inquiry ASET-1586 Mouse GFAP ELISA Kit (AC2997) Quantitative inquiry ASET-2281 Human Neurotensin ELISA Kit (AC3692) Quantitative inquiry ASET-1681 Mouse p75 NGF Receptor ELISA Kit (AC3092) Quantitative inquiry ASET-1494 Human Glutamate Receptor 1 (AMPA subtype) ELISA Kit (AC2905) Quantitative inquiry ASET-1650 Rat Estradiol ELISA Kit (AC3061) Quantitative inquiry ASET-1396 Human Glucose 6 Phosphate Isomerase ELISA Kit (AC2807) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
We are committed to accelerating progress in stroke research and drug development.
Copyright © Ace Therapeutics. All rights reserved.0Inquiry Basket